5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-thiol

Cat. No.: HY-W104752 Purity: 99.34%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-thiol (Compound 3n) is an antimicrobial and antioxidant agent, that inhibits Escherichia coli and Staphylococcus epidermidis, with MIC of 8 and 4 μg/mL. 5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-thiol exhibits antioxidant activity with IC₅₀ of 17.47 μM using DPPH free radical-scavenging method.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-thiol 화학구조

CAS No. : 15264-63-8

사이즈	재고	수량
250 mg	해외재고보유	Estimated Time of Arrival: December 31
1 g	해외재고보유	Estimated Time of Arrival: December 31
5 g	해외재고보유	Estimated Time of Arrival: December 31
25 g	해외재고보유	Estimated Time of Arrival: December 31
50 g	견적 받기

or 대량구매 문의

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
순도&문서
References
고객리뷰

제품 설명

Cellular Effect

Cell Line	Type	Value	Description	References
MCF7	IC₅₀	> 250 μM Compound: 9	Cytotoxicity against human MCF7 cells assessed as cell viability after 48 hrs by MTT assay Cytotoxicity against human MCF7 cells assessed as cell viability after 48 hrs by MTT assay	[PMID: 22309914]

분자량

179.20

화학식

C₇H₅N₃OS

CAS No.

15264-63-8

Appearance

Solid

Color

Light yellow to yellow

SMILES

C1=C(C=CN=C1)C2=NN=C(O2)S

선적

Room temperature in continental US; may vary elsewhere.

보관

4°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

순도&문서

Purity: 99.34%

Select Batch:

Data Sheet (268 KB) SDS (393 KB)

COA (249 KB) HNMR (113 KB) RP-HPLC (223 KB)

Handling Instructions (2659 KB)

References

[1]. Yarmohammadi E, et al., Ultrasound-assisted, low-solvent and acid/base-free synthesis of 5-substituted 1,3,4-oxadiazole-2-thiols as potent antimicrobial and antioxidant agents. Mol Divers. 2021 Nov;25(4):2367-2378. [Content Brief]